Argatroban

阿加曲班

Report date: 2026/03/24 15:27:25
NME

Base Information

Drug NameArgatroban
Drug Alias NameArgipidineDa BeiMQPAArganovaArgatrobanum +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProthrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsPostoperative ComplicationsHemorrhageThrombocytopenia +[10] 
Global Approved IndicationsThrombosis
Approved Indications in ChinaThrombosis
Original Approved Country/TerritoryJapan
Original Approved Date1990/01/23
Country/TerritoryCanadaUnited StatesAustria +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer IncMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesSandoz Canada IncorporatedAccord Healthcare IncMitsubishi Tanabe Pharma Corp +[7] 
Inactive CompaniesSandozThe University Of Texas Health Science Center At HoustonMedical University Of Innsbruck +[4] 
Active IndicationsPostoperative ComplicationsHemorrhageThrombocytopenia +[5] 
Inactive IndicationsVenous ThromboembolismStrokeBrain Ischemia +[5] 

Other Information

ATC CodeB01AE03
Related LinksWikipediaDrugBankKEGG